Agilent Technologies (NYSE:A) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.61-0.63 for the period, compared to the Thomson Reuters consensus estimate of $0.64. The company issued revenue guidance of $1.2-1.22 billion, compared to the consensus revenue estimate of $1.17 billion.Agilent Technologies also updated its FY18 guidance to $2.62-2.68 EPS.
Agilent Technologies (A) traded up $1.36 during trading hours on Wednesday, hitting $69.70. The company had a trading volume of 3,632,650 shares, compared to its average volume of 2,254,274. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85. Agilent Technologies has a fifty-two week low of $50.56 and a fifty-two week high of $75.00. The firm has a market cap of $22,410.00, a price-to-earnings ratio of 33.19, a price-to-earnings-growth ratio of 2.07 and a beta of 1.28.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the company posted $0.59 EPS. Agilent Technologies’s revenue for the quarter was up 7.0% on a year-over-year basis. analysts anticipate that Agilent Technologies will post 2.58 EPS for the current year.
In other news, insider Patrick Kaltenbach sold 7,358 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $69.28, for a total transaction of $509,762.24. Following the completion of the sale, the insider now directly owns 72,862 shares of the company’s stock, valued at approximately $5,047,879.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 43,703 shares of the firm’s stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $70.00, for a total value of $3,059,210.00. Following the sale, the chief executive officer now directly owns 302,837 shares of the company’s stock, valued at $21,198,590. The disclosure for this sale can be found here. Insiders have sold a total of 219,991 shares of company stock valued at $15,468,795 over the last ninety days.
WARNING: “Agilent Technologies (A) Releases Q2 Earnings Guidance” was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/02/14/agilent-technologies-a-releases-q2-earnings-guidance.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.